Gene, Cell, + RNA Therapy Landscape Report Q1 2024 Quarterly Data Report

In Q1 2024, there were more than 4,000 gene, cell, and RNA therapies in development. The field earned the approval of three new therapies — a CAR-T therapy for myeloma in China, an AAV gene therapy for hemophilia B in Canada, and an autologous cell therapy for melanoma in the United States.